Recruiting IgA Nephropathy Studies in Orlando
About IgA Nephropathy Clinical Trials in Orlando
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 3 iga nephropathy clinical trials recruiting participants in Orlando, FL. These studies are seeking a combined 70 participants. Research is being sponsored by Jade Biosciences, Inc., Novartis Pharmaceuticals, Biohaven Therapeutics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Orlando — FAQ
Are there iga nephropathy clinical trials in Orlando?
Yes, there are 3 iga nephropathy clinical trials currently recruiting in Orlando, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orlando?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orlando research site will contact you about next steps.
Are clinical trials in Orlando free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orlando studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 3 active trials in Orlando are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated October 12, 2026 from ClinicalTrials.gov